Home BPCIA: Amgen Begins the Patent Dance With AbbVie
 

Keywords :   


BPCIA: Amgen Begins the Patent Dance With AbbVie

2015-12-08 00:56:18| Biotech - Topix.net

On November 25, 2015, Amgen Inc. announced it submitted its first biologics license application to the FDA under the Section 351 biosimilar approval pathway provided in the Biologics Price Competition and Innovation Act . Amgen's BLA seeks approval for its biosimilar of AbbVie's top-selling arthritis drug Humira .

Tags: dance begins patent amgen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »